WASHER SUSAN B. (President and CEO) sold 6.5% of their position (9.95K shares) of APPLIED GENETIC TECHNOLOGIES CORP on the open market
Open‑market sale worth $21.7K — a moderate reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 2/22/2022ACC: 0001062993-22-005202
DirectorOfficer· President and CEO
Since Jul 2018
-9.95K
Net shares
Net seller
$21.7K
Total sold
1
Open market trades
0B · 1S
3
Total transactions
120.69K acquired · 130.64K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
+120.69K
Price / share
$0.35
Trade value
$42.24K
% of position
373.8%
2/18/2022
32.28K→152.97K
Common Stock
Direct
Shares
−9.95K
Price / share
$2.18
Trade value
$21.69K
% of position
6.5%
2/18/2022
152.97K→143.02K
Total
Net shares
+110.74K
Net value
$20.55K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 2/18/2022 | M · Option Exercise | +120.69K | $0.35 | $42.24K | 373.8% | 32.28K | 152.97K |
| Common Stock Direct | 2/18/2022 | S · Sale | −9.95K | $2.18 | $21.69K | 6.5% | 152.97K | 143.02K |
| Total | +110.74K | $20.55K | ||||||
Derivative Transactions1
Stock Option (right to buy)
Direct
Converts to
Common Stock
120.69K shares
Shares
−120.69K
Strike price
0.35
Held after
0.00
Exercisable
—
2/18/2022
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (right to buy) Direct | Common Stock120.69K shares | 2/18/2022 | M · Option Exercise | −120.69K | 0.35 | — | 0.00 |